Mitigating Risk in Drug Development Using AI

Presenters: Judy Carmody - Carmody Quality Solutions and current AGXPE BOD and Jonathan Vaught, Dynamic and accomplished business leader, founder, scientist and advisor, QI Path

The pharmaceutical industry faces significant challenges in drug development, particularly in managing the risks associated with long timelines, high costs, and uncertain clinical outcomes. This presentation explores how artificial intelligence (AI) can play a pivotal role in mitigating these risks by enhancing decision-making, optimizing clinical trial designs, and improving predictive models. We will discuss real-world GMP and GCP examples of AI applications.  Through these insights, this presentation aims to demonstrate how AI is transforming the landscape of drug development and driving more efficient, cost-effective, and safer pathways to bringing new treatments to market.

45 minutes of action packed and informative materrial followed by 15 minutes of Q&A